Chiasma, Inc. (CHMA) |
| 3.76 -0.24 (-6%) 04-24 15:47 |
| Open: | 4.08 |
| High: | 4.1 |
| Low: | 3.76 |
| Volume: | 8,196,718 |
| Market Cap: | 0(M) |
| PE Ratio: | -2.39 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 4.80 |
| Resistance 1: | 4.40 |
| Pivot price: | 4.15 |
| Support 1: | 3.76 |
| Support 2: | 3.13 |
| 52w High: | 5.74 |
| 52w Low: | 2.77 |
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
Financials
| EPS | -1.432 |
| Book Value | 1.590 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.018 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -2408.65 |
| Return on Assets (ttm) | -37.0 |
| Return on Equity (ttm) | -133.8 |
Company news
Tue, 27 Jul 2021
Pulmatrix Appoints Director Anand Varadan - citybiz
Thu, 27 May 2021
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CHMA, DSSI, WBT, HGV, PFBI; Shareholders are Encouraged to Contact the Firm - PR Newswire
Wed, 05 May 2021
Chiasma Stock Shoots Up On Being Acquired By Amryt Pharma In All Stock Deal - Yahoo Finance
Wed, 05 May 2021
Amryt Pharma to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases - GlobeNewswire
Mon, 11 Apr 2016
Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept Pharmaceuticals (NASDAQ:ICPT) Gilead Sciences, Inc (NASDAQ:GILD) Clovis Oncology, Inc. (NASDAQ:CLVS) Chiasma, Inc. (NASDAQ:CHMA) - marketexclusive.com
Fri, 30 Oct 2015
Chiasma Supports Acromegaly Awareness with Launch of New Online Resource for Patients and Caregivers - MultiVu
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
